Please contact our sales representative to learn more information about this reagents.
Background
Anifrolumab is a monoclonal antibody designed for the treatment of systemic lupus erythematosus (SLE). It binds to the type I interferon receptor, blocking the activity of type I interferons such as interferon-α and interferon-β.